Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login

Urology Journal

  • Home
  • Instant Online
    • Instant 2025
    • Instant 2024
    • Instant 2023
    • Instant 2022
    • Instant 2021
    • Instant 2020
  • Current
  • Archives
  • Announcements
  • Submissions
  • Author Guidelines
  • About
    • About the Journal
    • Editorial Team
    • Privacy Statement
    • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 10 No. 4 (2013): AUTUMN
  4. ORIGINAL PAPER(UROLOGICAL ONCOLOGY)

Vol. 10 No. 4 (2013)

January 2014

The Comparison between HumanLeukocyte Antigen System Incidence in Patients with Bladder Cancer and Normal Controls

  • Siavash Falahatkar
  • Hadiseh Donyamali
  • Mohammad Ali Joafshani
  • Reza Shahrokhi Damavand
  • Saba Hoda
  • Samaneh Esmaeili
  • Keivan Gholamjani Moghaddam
  • Sara Nikpour

Urology Journal, Vol. 10 No. 4 (2013), 4 January 2014 , Page 1059-1062
https://doi.org/10.22037/uj.v10i4.1441 Published: 2014-01-04

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Abstract

Purpose: To determine the frequency of human leukocyte antigen (HLA)-B5 in patients with bladder cancer compared with normal population.

 Materials and Methods: In this cross sectional study, from November 2009 until November 2010, 35 patients with pathologic diagnosis of bladder cancer who referred to urology clinic of Razi Hospital were studied. Also, 130 healthy transplant donation volunteers who referred for HLA-typing to Guilan Blood Transfusion Organization, were selected. Inclusion criterion was pathologic diagnosis of bladder cancer regardless of stage and grade of tumor. Exclusion criteria were presence of other urologic diseases. The information of these cases was extracted from medical records, collected and analyzed.

 Results: HLA-B5 was positive in 34.3% of the patient group and in 39.2% of the controls. Statistical analysis showed no significant association between HLA-B5 and bladder cancer (P = .15). There were no significant differences between grade (P = .107) and relapse (P = .327) of bladder tumor with presence of HLA-B5.

 Conclusion: There was no significant association between HLA-B5 and bladder cancer. The grade and the relapse of tumor had no association with presence or absence of HLA-B5.

 

  • PDF

How to Cite

Falahatkar, S., Donyamali, H., Joafshani, M. A., Shahrokhi Damavand, R., Hoda, S., Esmaeili, S., Gholamjani Moghaddam, K., & Nikpour, S. (2014). The Comparison between HumanLeukocyte Antigen System Incidence in Patients with Bladder Cancer and Normal Controls. Urology Journal, 10(4), 1059–1062. https://doi.org/10.22037/uj.v10i4.1441
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 323 times
  • PDF Downloaded: 247 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus